Redwan El-Rashdy M, Fahmy Ali, El Hanafy Amr, Abd El-Baky Nawal, Sallam Sobhy M A
Protein Research Department, Genetic Engineering and Biotechnology Research Institute, Mubarak City for Scientific Research and Technology Applications, Alexandria, Egypt.
Comp Immunol Microbiol Infect Dis. 2009 Jan;32(1):9-19. doi: 10.1016/j.cimid.2007.11.004. Epub 2008 Feb 19.
In view of the disadvantages of human and equine rabies immunoglobulin still there is urgent needs for safe and cost-control anti-rabies immunoglobulins especially for person who have been severely exposed (categories III) to the virus. Our attempt to produce a less immunogenic and cheaper anti-rabies immunoglobulin affordable for those people living in developing countries, has been harnessed the ovine as a bioreactor instead the horse. The animals have been intramuscular immunized, and the plasma processed with 5% caprylic acid to yield IgG with purity of 95%. Moreover, antibody apparently indicated that the titer and neutralizing indexes were harmonized, especially at higher antibody dilution. The results showed that three immunized sheep were produced about 7000 IU of purified anti-rabies antibody. Sheep's IgG has low immunogenic effect than human and horse antibodies when injected into the mouse. Pure concentrated ovine antibody may serve as a possible alternative to currently available anti-rabies human or equine immunoglobulin.
鉴于人用和马用狂犬病免疫球蛋白存在的缺点,对于严重暴露于病毒的人群(III类),迫切需要安全且成本可控的抗狂犬病免疫球蛋白。我们尝试利用绵羊作为生物反应器而非马,来生产免疫原性较低且价格更便宜、适合发展中国家人群使用的抗狂犬病免疫球蛋白。这些动物经肌肉注射免疫,血浆用5%辛酸处理以产生纯度为95%的IgG。此外,抗体明显表明效价和中和指数是协调一致的,尤其是在较高抗体稀释度时。结果显示,三只免疫的绵羊产生了约7000国际单位的纯化抗狂犬病抗体。当注射到小鼠体内时,绵羊IgG的免疫原性效应低于人用和马用抗体。纯浓缩绵羊抗体可能成为现有抗狂犬病人用或马用免疫球蛋白的一种可行替代物。